Annual report pursuant to Section 13 and 15(d)

Stock Plans (Tables)

v3.22.0.1
Stock Plans (Tables)
12 Months Ended
Dec. 31, 2021
Schedule of Stock-based Compensation Expense The stock-based compensation expense by type of award and by operating expense grouping are presented below:

 

 

 

Year Ended

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

Stock-based compensation expense by type of award:

 

 

 

 

 

 

 

 

Restricted stock units

 

$

19,088

 

 

$

5,560

 

Restricted stock awards

 

 

19

 

 

 

181

 

Machine Box contingent common stock issuances

 

 

 

 

 

(37

)

Performance-based stock options

 

 

16,315

 

 

 

8,480

 

Stock options

 

 

3,720

 

 

 

4,767

 

Employee stock purchase plan

 

 

423

 

 

 

493

 

Common stock issued for services

 

 

500

 

 

 

95

 

Total

 

$

40,065

 

 

$

19,539

 

 

 

 

 

 

 

 

 

 

Stock-based compensation expense by operating expense grouping:

 

 

 

 

 

 

 

 

Cost of revenue

 

$

116

 

 

 

 

Sales and marketing

 

 

1,716

 

 

 

889

 

Research and development

 

 

3,217

 

 

 

1,046

 

General and administrative

 

 

35,016

 

 

 

17,604

 

 

 

$

40,065

 

 

$

19,539

 

 

Schedule of Restricted Stock Award Activity

The Company’s restricted stock award activity for the year ended December 31, 2021 was as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2020

 

 

 

 

$

 

Granted

 

 

581

 

 

$

32.33

 

Vested

 

 

(581

)

 

$

32.33

 

Unvested at December 31, 2021

 

 

 

 

 

 

 

 

Schedule of Restricted Stock Unit Activity

The Company’s restricted stock units activity for the year ended December 31, 2021 was as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2020

 

 

829,124

 

 

$

11.53

 

Granted

 

 

896,329

 

 

$

33.33

 

Forfeited

 

 

(34,618

)

 

$

39.00

 

Vested

 

 

(804,374

)

 

$

11.47

 

Unvested at December 31, 2021

 

 

886,461

 

 

$

32.56

 

 

 

Schedule of Stock Option Activity

The activity related to all other stock options for the year ended December 31, 2021 was as follows:

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

 

 

 

Exercise

 

 

Contractual

 

Intrinsic

 

 

 

Options

 

 

Price

 

 

Term

 

Value

 

Outstanding at December 31, 2020

 

 

5,400,070

 

 

$

12.60

 

 

 

 

 

 

 

Granted

 

 

848,955

 

 

$

28.18

 

 

 

 

 

 

 

Exercised

 

 

(515,807

)

 

$

9.58

 

 

 

 

 

 

 

Forfeited

 

 

(220,109

)

 

$

17.45

 

 

 

 

 

 

 

Expired

 

 

(4,501

)

 

$

7.48

 

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

5,508,608

 

 

$

15.10

 

 

6.23 years

 

$

45,262

 

Exercisable at December 31, 2021

 

 

4,207,518

 

 

$

13.71

 

 

5.62 years

 

$

36,982

 

 

Employee Stock Purchase Plan [Member]  
Summary of Fair Value Assumptions of Stock Purchase Plan

The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the years ended December 31, 2021 and 2020 are set forth in the table below:

 

 

Year Ended

 

 

Year Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2021

 

 

2020

 

Expected term (in years)

 

0.5 - 2.0

 

 

0.5 - 2.0

 

Expected volatility

 

67% - 119%

 

 

65% - 130%

 

Risk-free interest rate

 

 

0.1

%

 

0.1% - 1.5%

 

Expected dividend yield

 

 

 

 

 

 

 

2018 Performance Base Stock Incentive Plan [Member]  
Summary of Fair Value Assumptions of Performance Awards

The assumptions used in the Monte Carlo simulation model for computing the fair values of the Performance Options on the August 2020 modification date and immediately before the modification are set forth in the table below:

 

Amendment date stock price

 

$

8.83

 

Expected volatility

 

 

80

%

Risk-free interest rate

 

 

0.6

%

Expected dividend yield

 

 

%

Cost of equity

 

 

12

%

 

Timebased Stock Option [Member]  
Schedule of Fair Value Assumptions The assumptions used in calculating the fair values of time-based stock options granted during the years ended December 31, 2021 and 2020 are set forth in the table below:

 

 

Year Ended

 

 

Year Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2021

 

 

2020

 

Expected term (in years)

 

5.5 - 6.1

 

 

6.0 - 6.1

 

Expected volatility

 

80% - 83%

 

 

68% - 83%

 

Risk-free interest rate

 

0.6% - 1.4%

 

 

0.4% - 1.2%

 

Expected dividend yield

 

 

 

 

 

 

 

Performance-based Stock Options [Member]  
Summary of Fair Value Assumptions of Stock Purchase Plan

The Company values Performance Options using a Monte Carlo simulation model. A fair value per share is determined for each of the three equal tranches of each Performance Option. No Performance Options were granted during the year ended December 31, 2021. The assumptions used in the Monte Carlo simulation model for computing the grant date fair values of the Performance Options granted during the year ended December 31, 2020 are set forth in the table below:

 

 

 

Year Ended

 

 

 

 

December 31,

 

 

 

 

2020

 

 

Grant date stock price

 

$

11.10

 

 

Dividend yield

 

 

%

 

Risk-free interest rate

 

 

0.8

%

 

Estimated volatility

 

 

85

%

 

 

 

Schedule of Stock Option Activity

The activity related to Performance Options for the year ended December 31, 2021 was as follows:

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

 

 

 

Exercise

 

 

Contractual

 

Intrinsic

 

 

 

Options

 

 

Price

 

 

Term

 

Value

 

Outstanding at December 31, 2020

 

 

4,234,020

 

 

$

10.55

 

 

 

 

 

 

 

Exercised

 

 

(373,041

)

 

$

5.77

 

 

 

 

 

 

 

Forfeited

 

 

(12,552

)

 

$

5.92

 

 

 

 

 

 

 

Expired

 

 

(13,986

)

 

$

5.41

 

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

3,834,441

 

 

$

11.05

 

 

6.51 years

 

$

438,278

 

Exercisable at December 31, 2021

 

 

3,834,441

 

 

$

11.05

 

 

6.51 years

 

$

438,278